These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8394672)

  • 1. Evidence for a role of EGF receptor in the progression of human lung carcinoma.
    Pavelic K; Banjac Z; Pavelic J; Spaventi S
    Anticancer Res; 1993; 13(4):1133-7. PubMed ID: 8394672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
    Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
    Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
    J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
    Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
    Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
    Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF-R expression in ductal breast cancer: proliferation and prognostic implications.
    Bucci B; D'Agnano I; Botti C; Mottolese M; Carico E; Zupi G; Vecchione A
    Anticancer Res; 1997; 17(1B):769-74. PubMed ID: 9066618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased estrogen receptor and epidermal growth factor receptor gene product co-expression in surgically resected gastric adenocarcinomas.
    Koullias GJ; Kouraklis GP; Raftopoulos IS; Davaris PS; Papadopoulos SA; Golematis BC
    J Surg Oncol; 1996 Nov; 63(3):166-71. PubMed ID: 8944060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
    Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
    Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells.
    Radinsky R; Risin S; Fan D; Dong Z; Bielenberg D; Bucana CD; Fidler IJ
    Clin Cancer Res; 1995 Jan; 1(1):19-31. PubMed ID: 9815883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas.
    Macias A; Azavedo E; Hägerström T; Klintenberg C; Pérez R; Skoog L
    Anticancer Res; 1987; 7(3 Pt B):459-64. PubMed ID: 3631906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-R and PCNA expression in ovarian carcinomas--correlation with classic prognostic factors.
    Minguillon C; Schönborn I; Reles A; Bartel U; Lichtenegger W
    Gen Diagn Pathol; 1996 Mar; 141(3-4):197-201. PubMed ID: 8705783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis.
    Irving JA; Young RH
    Am J Surg Pathol; 2005 Aug; 29(8):997-1006. PubMed ID: 16006793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines.
    Al Moustafa AE; Yansouni C; Alaoui-Jamali MA; O'Connor-McCourt M
    Clin Cancer Res; 1999 Mar; 5(3):681-6. PubMed ID: 10100722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
    Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer.
    Uegaki K; Nio Y; Inoue Y; Minari Y; Sato Y; Song MM; Dong M; Tamura K
    Anticancer Res; 1997; 17(5B):3841-7. PubMed ID: 9427790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.